Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Screening children for pulmonary arteriovenous malformations: Evaluation of 18 years of experience.

Hosman AE, de Gussem EM, Balemans WAF, Gauthier A, Westermann CJJ, Snijder RJ, Post MC, Mager JJ.

Pediatr Pulmonol. 2017 Sep;52(9):1206-1211. doi: 10.1002/ppul.23704. Epub 2017 Apr 13.

PMID:
28407366
2.

Sensitization predicts asthma development among wheezing toddlers in secondary healthcare.

Boersma NA, Meijneke RWH, Kelder JC, van der Ent CK, Balemans WAF.

Pediatr Pulmonol. 2017 Jun;52(6):729-736. doi: 10.1002/ppul.23668. Epub 2017 Jan 11.

PMID:
28076664
3.

Clinical relevance and cost-effectiveness of HLA genotyping in children with Type 1 diabetes mellitus in screening for coeliac disease in the Netherlands.

Elias J, Hoorweg-Nijman JJ, Balemans WA.

Diabet Med. 2015 Jun;32(6):834-8. doi: 10.1111/dme.12658. Epub 2014 Dec 28.

PMID:
25546232
4.

Respiratory tract infections and asthma control in children.

Zomer-Kooijker K, Uiterwaal CS, Verschueren KJ, Maitland-vd Zee AH, Balemans WA, van Ewijk BE, van Velzen MF, van der Ent CK.

Respir Med. 2014 Oct;108(10):1446-52. doi: 10.1016/j.rmed.2014.07.007. Epub 2014 Jul 22.

5.

Diagnostic properties of C-reactive protein for detecting pneumonia in children.

Koster MJ, Broekhuizen BD, Minnaard MC, Balemans WA, Hopstaken RM, de Jong PA, Verheij TJ.

Respir Med. 2013 Jul;107(7):1087-93. doi: 10.1016/j.rmed.2013.04.012. Epub 2013 May 11.

6.

The expert network and electronic portal for children with respiratory and allergic symptoms: rationale and design.

Zomer-Kooijker K, van Erp FC, Balemans WA, van Ewijk BE, van der Ent CK; Expert Network for Children with Respiratory and Allergic Symptoms.

BMC Pediatr. 2013 Jan 16;13:9. doi: 10.1186/1471-2431-13-9.

7.

Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria.

Balemans W, Vranckx L, Lounis N, Pop O, Guillemont J, Vergauwen K, Mol S, Gilissen R, Motte M, Lançois D, De Bolle M, Bonroy K, Lill H, Andries K, Bald D, Koul A.

Antimicrob Agents Chemother. 2012 Aug;56(8):4131-9. doi: 10.1128/AAC.00273-12. Epub 2012 May 21.

8.

[Diagnosis of fetal alcohol spectrum disorders].

van Wieringen H, Letteboer TG, Pereira RR, de Ruiter S, Balemans WA, Lindhout D.

Ned Tijdschr Geneeskd. 2010;154:A331. Review. Dutch.

PMID:
20858301
9.

Common genetic variation in the DKK1 gene is associated with hip axis length but not with bone mineral density and bone turnover markers in young adult men: results from the Odense Androgen Study.

Piters E, Balemans W, Nielsen TL, Andersen M, Boudin E, Brixen K, Van Hul W.

Calcif Tissue Int. 2010 Apr;86(4):271-81. doi: 10.1007/s00223-010-9334-7. Epub 2010 Jan 26.

PMID:
20101398
10.

Essentiality of FASII pathway for Staphylococcus aureus.

Balemans W, Lounis N, Gilissen R, Guillemont J, Simmen K, Andries K, Koul A.

Nature. 2010 Jan 21;463(7279):E3; discussion E4. doi: 10.1038/nature08667.

PMID:
20090698
11.

Sclerostin in mineralized matrices and van Buchem disease.

van Bezooijen RL, Bronckers AL, Gortzak RA, Hogendoorn PC, van der Wee-Pals L, Balemans W, Oostenbroek HJ, Van Hul W, Hamersma H, Dikkers FG, Hamdy NA, Papapoulos SE, Löwik CW.

J Dent Res. 2009 Jun;88(6):569-74. doi: 10.1177/0022034509338340.

PMID:
19587164
12.

A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin.

Kim CA, Honjo R, Bertola D, Albano L, Oliveira L, Jales S, Siqueira J, Castilho A, Balemans W, Piters E, Jennes K, Van Hul W.

Genet Test. 2008 Dec;12(4):475-9. doi: 10.1089/gte.2008.0036.

PMID:
19072561
13.

Recurrent sclerosing dysplasia of bone: report of a case.

Batstone MD, Walton G, Lynham A, Monsour F, Balemans W, Van Hul W.

J Oral Maxillofac Surg. 2008 Nov;66(11):2372-4. doi: 10.1016/j.joms.2007.12.034. No abstract available.

PMID:
18940508
14.

Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis.

Koul A, Vranckx L, Dendouga N, Balemans W, Van den Wyngaert I, Vergauwen K, Göhlmann HW, Willebrords R, Poncelet A, Guillemont J, Bald D, Andries K.

J Biol Chem. 2008 Sep 12;283(37):25273-80. doi: 10.1074/jbc.M803899200. Epub 2008 Jul 14.

15.

Genetic analysis and effect of triiodothyronine and prednisone trial on bone turnover in a patient with craniotubular hyperostosis.

López JM, Balemans W, Piters E, Van Hul W, González G.

Bone. 2008 Aug;43(2):405-9. doi: 10.1016/j.bone.2008.04.011. Epub 2008 Apr 29.

PMID:
18538647
16.

The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.

Balemans W, Piters E, Cleiren E, Ai M, Van Wesenbeeck L, Warman ML, Van Hul W.

Calcif Tissue Int. 2008 Jun;82(6):445-53. doi: 10.1007/s00223-008-9130-9.

PMID:
18521528
17.

Atopic disease and exhaled nitric oxide in an unselected population of young adults.

van Asch CJ, Balemans WA, Rovers MM, Schilder AG, van der Ent CK.

Ann Allergy Asthma Immunol. 2008 Jan;100(1):59-65. doi: 10.1016/S1081-1206(10)60406-1.

PMID:
18254484
18.

Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense androgen study.

Brixen K, Beckers S, Peeters A, Piters E, Balemans W, Nielsen TL, Wraae K, Bathum L, Brasen C, Hagen C, Andersen M, Van Hul W, Abrahamsen B.

Calcif Tissue Int. 2007 Dec;81(6):421-9. Epub 2007 Dec 4.

19.

The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.

Balemans W, Van Hul W.

Endocrinology. 2007 Jun;148(6):2622-9. Epub 2007 Mar 29. Review.

PMID:
17395706
20.

Exclusion of OGDH and BMP4 as candidate genes in two siblings with autosomal recessive DOOR syndrome.

van Bever Y, Balemans W, Duval EL, Jespers A, Eyskens F, van Hul W, Courtens W.

Am J Med Genet A. 2007 Apr 1;143A(7):763-7. No abstract available.

PMID:
17343268
21.

Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.

Balemans W, Devogelaer JP, Cleiren E, Piters E, Caussin E, Van Hul W.

J Bone Miner Res. 2007 May;22(5):708-16.

22.

Human genetics of SOST.

Balemans W, Van Hul W.

J Musculoskelet Neuronal Interact. 2006 Oct-Dec;6(4):355-6. Review. No abstract available.

23.

[Wheezing and cough related to congenital airway abnormalities in young infants].

van Veen M, Balemans WA, Schipper JA, Arets HG.

Ned Tijdschr Geneeskd. 2006 Sep 16;150(37):2009-12. Dutch.

PMID:
17058454
24.

Prediction of asthma in young adults using childhood characteristics: Development of a prediction rule.

Balemans WA, van der Ent CK, Schilder AG, Sanders EA, Zielhuis GA, Rovers MM.

J Clin Epidemiol. 2006 Nov;59(11):1207-12. Epub 2006 Aug 24.

PMID:
17027432
25.

Persistence of upper respiratory tract infections in a cohort followed from childhood to adulthood.

Rovers MM, Balemans WA, Sanders EA, van der Ent CK, Zielhuis GA, Schilder AG.

Fam Pract. 2006 Jun;23(3):286-90. Epub 2006 Mar 3.

PMID:
16517546
26.

Recurrent childhood upper respiratory tract infections do not reduce the risk of adult atopic disease.

Balemans WA, Rovers MM, Schilder AG, Sanders EA, Kimpen JL, Zielhuis GA, Ent CK.

Clin Exp Allergy. 2006 Feb;36(2):198-203.

PMID:
16433857
27.

Adenoidectomy and/or tonsillectomy in childhood is not associated with atopic disease later in life.

van Hattum ES, Balemans WA, Rovers MM, Zielhuis GA, Schilder AG, van der Ent CK.

Clin Exp Allergy. 2006 Jan;36(1):40-3.

PMID:
16393264
28.

A clinical and molecular overview of the human osteopetroses.

Balemans W, Van Wesenbeeck L, Van Hul W.

Calcif Tissue Int. 2005 Nov;77(5):263-74. Epub 2005 Nov 16. Review.

PMID:
16307387
29.

Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men.

Crabbe P, Balemans W, Willaert A, van Pottelbergh I, Cleiren E, Coucke PJ, Ai M, Goemaere S, van Hul W, de Paepe A, Kaufman JM.

J Bone Miner Res. 2005 Nov;20(11):1951-9. Epub 2005 Jul 11.

30.

An autosomal dominant high bone mass phenotype in association with craniosynostosis in an extended family is caused by an LRP5 missense mutation.

Kwee ML, Balemans W, Cleiren E, Gille JJ, Van Der Blij F, Sepers JM, Van Hul W.

J Bone Miner Res. 2005 Jul;20(7):1254-60. Epub 2005 Mar 7.

31.

A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.

Balemans W, Cleiren E, Siebers U, Horst J, Van Hul W.

Bone. 2005 Jun;36(6):943-7.

PMID:
15869924
32.

Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target?

Balemans W, Van Hul W.

J Musculoskelet Neuronal Interact. 2004 Jun;4(2):139-42. Review.

33.

Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal.

Wergedal JE, Veskovic K, Hellan M, Nyght C, Balemans W, Libanati C, Vanhoenacker FM, Tan J, Baylink DJ, Van Hul W.

J Clin Endocrinol Metab. 2003 Dec;88(12):5778-83.

PMID:
14671168
34.

Van Buchem disease: lifetime evolution of radioclinical features.

Vanhoenacker FM, Balemans W, Tan GJ, Dikkers FG, De Schepper AM, Mathysen DG, Bernaerts A, Hul WV.

Skeletal Radiol. 2003 Dec;32(12):708-18. Epub 2003 Oct 1.

PMID:
14520501
35.

Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms.

Balemans W, Foernzler D, Parsons C, Ebeling M, Thompson A, Reid DM, Lindpaintner K, Ralston SH, Van Hul W.

Bone. 2002 Oct;31(4):515-9.

PMID:
12398949
36.

Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators.

Balemans W, Van Hul W.

Dev Biol. 2002 Oct 15;250(2):231-50. Review.

37.

Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.

Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, Van Hul W.

J Med Genet. 2002 Feb;39(2):91-7.

38.

Molecular and radiological diagnosis of sclerosing bone dysplasias.

Van Hul W, Vanhoenacker F, Balemans W, Janssens K, De Schepper AM.

Eur J Radiol. 2001 Dec;40(3):198-207. Review.

PMID:
11731208
39.

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).

Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W.

Hum Mol Genet. 2001 Mar 1;10(5):537-43.

PMID:
11181578
40.

Sclerosing bone dysplasias: genetic and radioclinical features.

Vanhoenacker FM, De Beuckeleer LH, Van Hul W, Balemans W, Tan GJ, Hill SC, De Schepper AM.

Eur Radiol. 2000;10(9):1423-33. Review.

PMID:
10997431
41.

Refined localization and two additional linked families for the DFNA10 locus for nonsyndromic hearing impairment.

Verhoeven K, Fagerheim T, Prasad S, Wayne S, De Clau F, Balemans W, Verstreken M, Schatteman I, Solem B, Van de Heyning P, Tranebjärg L, Smith RJ, Van Camp G.

Hum Genet. 2000 Jul;107(1):7-11.

PMID:
10982027
42.

Classical Friedreich's ataxia and its genotype.

Martin J, Martin L, Löfgren A, D'Hooghe M, Storm K, Balemans W, Palau F, Van Broeckhoven C.

Eur Neurol. 1999;42(2):109-15.

PMID:
10473983
43.

Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.

Balemans W, Van Den Ende J, Freire Paes-Alves A, Dikkers FG, Willems PJ, Vanhoenacker F, de Almeida-Melo N, Alves CF, Stratakis CA, Hill SC, Van Hul W.

Am J Hum Genet. 1999 Jun;64(6):1661-9.

44.

Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity.

Haslam SI, Van Hul W, Morales-Piga A, Balemans W, San-Millan JL, Nakatsuka K, Willems P, Haites NE, Ralston SH.

J Bone Miner Res. 1998 Jun;13(6):911-7.

45.

Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21.

Van Hul W, Balemans W, Van Hul E, Dikkers FG, Obee H, Stokroos RJ, Hildering P, Vanhoenacker F, Van Camp G, Willems PJ.

Am J Hum Genet. 1998 Feb;62(2):391-9.

46.

Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea.

Van Laer L, Van Camp G, van Zuijlen D, Green ED, Verstreken M, Schatteman I, Van de Heyning P, Balemans W, Coucke P, Greinwald JH, Smith RJ, Huizing E, Willems P.

Eur J Hum Genet. 1997 Nov-Dec;5(6):397-405.

PMID:
9450185
47.

A gene for autosomal dominant nonsyndromic hearing loss (DFNA12) maps to chromosome 11q22-24.

Verhoeven K, Van Camp G, Govaerts PJ, Balemans W, Schatteman I, Verstreken M, Van Laer L, Smith RJ, Brown MR, Van de Heyning PH, Somers T, Offeciers FE, Willems PJ.

Am J Hum Genet. 1997 May;60(5):1168-73.

48.

The gene for Pendred syndrome is located between D7S501 and D7S692 in a 1.7-cM region on chromosome 7q.

Coucke P, Van Camp G, Demirhan O, Kabakkaya Y, Balemans W, Van Hauwe P, Van Agtmael T, Smith RJ, Parving A, Bolder CH, Cremers CW, Willems PJ.

Genomics. 1997 Feb 15;40(1):48-54.

PMID:
9070918
49.

Positional cloning of a gene involved in hereditary multiple exostoses.

Wuyts W, Van Hul W, Wauters J, Nemtsova M, Reyniers E, Van Hul EV, De Boulle K, de Vries BB, Hendrickx J, Herrygers I, Bossuyt P, Balemans W, Fransen E, Vits L, Coucke P, Nowak NJ, Shows TB, Mallet L, van den Ouweland AM, McGaughran J, Halley DJ, Willems PJ.

Hum Mol Genet. 1996 Oct;5(10):1547-57.

PMID:
8894688
50.

Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15.

van Camp G, Coucke P, Balemans W, van Velzen D, van de Bilt C, van Laer L, Smith RJ, Fukushima K, Padberg GW, Frants RR, et al.

Hum Mol Genet. 1995 Nov;4(11):2159-63.

PMID:
8589696

Supplemental Content

Loading ...
Support Center